Gaurav Bissa, Derivatives Analyst at LKP Securities told CNBC-TV18, "Biocon has been witnessing a smart move. It has now closed above the 200 day moving average (DMA) which is around Rs 465. It has been building up long positions; it is properly placed.”
“If you look at the comparisons with other peers they have moved up. This is one stock which has been struggling to hold Rs 465-470 levels. So, if these levels are held I suppose a target price of Rs 490 cannot be ruled out in the stock. One can keep a stoploss at Rs 460,” he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!